The scientists analysed blood sample DNA from 119 postmenopausal women who went on to develop breast cancer over a period of up to 12 years, and 122 who remained cancer-free.
Negative controls, including no-template and template from unused swabs, were included at all steps to control for potential primer or sample DNA contamination.